首页> 美国卫生研究院文献>other >Palonosetron versus older 5-HT3 receptor antagonists for nausea prevention in patients receiving chemotherapy: a multistudy analysis

【2h】

Palonosetron versus older 5-HT3 receptor antagonists for nausea prevention in patients receiving chemotherapy: a multistudy analysis

机译：帕洛诺司琼与较老的5-HT3受体拮抗剂在接受化疗的患者中预防恶心的多因素分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundNo clinical standard currently exists for the optimal management of nausea induced by emetogenic chemotherapy, particularly delayed nausea.

机译：背景技术目前尚无临床标准可用于最佳治疗由促生化学疗法引起的恶心，尤其是延迟性恶心。

著录项

期刊名称 other
作者
Gary R Morrow; Lee Schwartzberg; Sally Y Barbour; Gianluca Ballinari; Michael D Thorn; David Cox;
展开▼
作者单位

展开▼
年(卷),期 -1(12),7
年度 -1
页码 250–258
总页数 16
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Palonosetron versus older 5-HT_3 receptor antagonists for nausea prevention in patients receiving chemotherapy: a multistudy analysis [J] . Gary R Morrow, Lee Schwartzberg, Sally Y Barbour, The journal of supportive oncology. . 2014,第7期

机译：帕洛诺司琼与较老的5-HT_3受体拮抗剂预防化疗患者的恶心：一项多研究分析
2. Chemotherapy-induced nausea and vomiting and antiemetic prophylaxis with palonosetron versus other 5-HT3 receptor antagonists in patients with cancer treated with low emetogenic chemotherapy in a hospital outpatient setting in the United States [J] . SchwartzbergL., MorrowG., BaluS., Current medical research and opinion . 2011,第8期

机译：在美国医院门诊患者中，用帕洛诺司琼与其他5-HT3受体拮抗剂进行化学疗法诱导的恶心，呕吐和止吐预防
3. Palonosetron versus other 5-HT(3) receptor antagonists for prevention of chemotherapy-induced nausea and vomiting in patients with cancer on chemotherapy in a hospital outpatient setting. [J] . Balu S, Buchner D, Craver C, Clinical therapeutics . 2011,第4期

机译：帕洛诺司琼与其他5-HT（3）受体拮抗剂在医院门诊接受化疗的癌症患者中预防化疗引起的恶心和呕吐。
4. The Effect of Acupressure Wristbands Toward Acute Nausea and Vomiting on Post-Chemotherapy Cervix Cancer Patient in Prof. Dr. Margono Soekarjo Hospital Purwokerto [C] . Efita Yulianasari, Siti Haniyah, Indri Heri Susanti International Conference on Community Health . 2020

机译：Acu压抑腕带对急性恶心的影响，呕吐在化疗后宫颈癌患者Margono Soekarjo医院Purwokerto博士
5. Aprepitant for the Prevention of Acute Chemotherapy-induced Nausea and Vomiting in Children: Overcoming Barriers [D] . Patel, Priya 2018

机译：预防急性化疗引起的儿童恶心和呕吐的阿瑞品：克服障碍
6. Randomized phase III trial of APF530 versus palonosetron in the prevention of chemotherapy-induced nausea and vomiting in a subset of patients with breast cancer receiving moderately or highly emetogenic chemotherapy [O] . Ralph Boccia, Erin O’Boyle, William Cooper 2016

机译：APF530与帕洛诺司琼在预防中度或高度致呕性化疗的部分乳腺癌患者中化疗引起的恶心和呕吐的预防性随机III期试验
7. PCN48 IMPACT ON HOSPITAL OUTPATIENT VISIT COSTS BY INITIATING PALONOSETRON VERSUS OTHER 5-HYDROXYTRYPTAMINE3 RECEPTOR ANTAGONISTS FOR PREVENTION OF CHEMOTHERAPY INDUCED NAUSEA AND VOMITING (CINV) AMONG PATIENTS WITH CANCER [O] . Craver C., Gayle J., Balu S., 2011

机译：PCN48通过启动帕洛诺西酮与其他5-羟丙胺3受体拮抗剂以预防化疗引起的恶心和癌症患者呕吐（CINV）对医院门诊的影响

Palonosetron versus older 5-HT3 receptor antagonists for nausea prevention in patients receiving chemotherapy: a multistudy analysis

摘要

著录项

相似文献

相关主题

期刊订阅